4.2 Introduction to signal transduction: receptorsThe receptor is the ear

A signal transduction pathway links the reception of a signal to a response in the cell. Signaling begins when a receptor protein in the target cell recognizes its chemical messenger, called the ligand. The part of the receptor that binds the ligand is the ligand-binding domain, and it is specific: it recognizes one messenger, which can be a peptide (a small protein), a small chemical, or a protein, in a one-to-one relationship. Specific binding works just like an enzyme and its substrate: shape and charge must fit.
?Wait, why can some molecules cross the membrane and not others?
That decides where the receptor is. Most ligands are polar or large, like peptide hormones and neurotransmitters, so they can't cross the membrane: their receptors sit in the plasma membrane, with the ligand-binding domain facing outside. Small nonpolar ligands, like the steroid hormones testosterone and estrogen, diffuse straight through the membrane and bind receptors in the cytoplasm or the nucleus. The steroid and its receptor then act on DNA to change gene expression.
Two families of membrane receptors are in the course. G protein-coupled receptors (GPCRs) are the most common receptors in eukaryotes. When a ligand binds a GPCR, the receptor's shape changes and it activates a G protein on the inside of the membrane, which in turn activates an enzyme. Ligand-gated ion channels are channels that open or close when their ligand binds, so ions flow (or stop flowing) across the membrane. Many neurotransmitters work this way, which is why nerve signals can be so fast.
| Receptor | Where | Typical ligand | What binding does |
|---|---|---|---|
| G protein-coupled receptor (GPCR) | Plasma membrane | Many peptide hormones; epinephrine | Activates a G protein inside, which activates an enzyme (often making cAMP) |
| Ligand-gated ion channel | Plasma membrane | Neurotransmitters | Opens or closes the channel, so ions flow or stop |
| Intracellular receptor | Cytoplasm or nucleus | Small nonpolar signals: steroid hormones | Ligand-receptor complex changes gene expression |
?Wait, how does an ion channel change a cell?
I thought about it. Show me
- (a) Hormone B's effect is blocked; hormone A's is not.
Why?
Only the peptide relies on a surface receptor. - (b) The steroid is small and nonpolar, so it diffuses through the membrane and binds a receptor inside the cell, which the drug can't reach. The peptide is polar and large, so it must bind a surface receptor.
Why?
Tie location to polarity and size: the membrane rules from Unit 2. - (c) The steroid's effect, which works by changing gene expression, usually takes longer (time to make new mRNA and protein). A surface receptor pathway can change existing proteins within seconds to minutes.
Why?
This is a reasonable prediction with a mechanism; the exam rewards the mechanism.
Answer: (a) B is blocked. (b) The nonpolar steroid binds an intracellular receptor; the polar peptide needs a surface receptor. (c) The steroid acts more slowly, through gene expression.
Stuck? Get a hint
- Which hormone can cross the membrane?
- Where must the receptor be for a ligand that can't cross?
- Changing gene expression means making new proteins, which takes time.
- AInsulin, a protein hormone
- BTestosterone, a steroid hormone
- CA neurotransmitter that opens an ion channel
- DEpinephrine, which binds a GPCR
Show the answer
B. Testosterone is a small nonpolar steroid that crosses the membrane and binds an intracellular receptor. Insulin, neurotransmitters and epinephrine all bind receptors in the plasma membrane.
- Signaling begins when a ligand binds the specific ligand-binding domain of a receptor.
- Ligands can be peptides, small chemicals or proteins. Polar or large ligands bind surface receptors; small nonpolar ones (steroids) bind receptors in the cytoplasm or nucleus.
- GPCRs activate a G protein, which activates an enzyme. Ligand-gated ion channels open or close when the ligand binds.